News and Announcements
Major US Footwear Brand Adopts YPB Authentication Solution
- Published March 11, 2016 1:24PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
11th March 2016, ASX Announcement
Highlights:
- YPB anti-counterfeit technology to protect a major US brand of casual footwear
- Customer is a world leader in innovative casual footwear for men, women and children
- YPB providing its invisible tracer and scanner solution to the brand’s Chinese manufacturer
Anti-counterfeiting technology company YPB Group Limited (ASX: YPB) has entered into a three year contract to provide its invisible supply chain authentication solution to a major US casual footwear brand, incorporating the tracer technology into more than 70% of its entire production.
The brand is a world leader in innovative casual footwear for men, women and children. Having sold in excess of 300 million pairs since 2002 in more 90 countries it now manufactures 4 million pairs monthly in China.
The brand chose YPB’s solution to protect its brand and customers against possible counterfeit as it sought an innovative covert solution that provided high security protection at a competitive cost.
To read the full announcement, please click here.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
